Baiyunshan (600332.SH) subsidiary receives Macau Pharmaceutical Registration Certificate

Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (“Tianxin Pharmaceutical”), a holding subsidiary of the company, received the “Proprietary Drug Registration Certificate” issued by the Macau Special Administrative Region Government Drug Administration. Drug name: injectable cefazoline sodium (0.5g, 1.0g).

The drug has passed the consistent evaluation of the quality and efficacy of the national generic drug. After obtaining the “Proprietary Drug Registration Certificate” issued by the Drug Administration of the Macao Special Administrative Region Government, the drug will be sold by Tianxin Pharmaceutical as an authorized exporter and wholesaler of Guangzhou Pharmaceutical International (Macau) pharmaceutical products in the Macau region, which will help Tianxin Pharmaceutical expand overseas market business and enhance the market competitiveness of the company's products.